- Beyond Medical Technologies (DOCT) has announced plans to consolidate its common shares on a ten-to-one basis
- The consolidation will take effect from December 30, 2022
- The new CUSIP number will be 088641204, and the new ISIN number will be CA0886412042 for the post-consolidation common shares
- Beyond Medical is an industrial-cum-technology company with a manufacturing facility located in Delta, British Columbia
- Beyond Medical Technologies was down 33.33 per cent, trading at $0.01 at 13:04 ET
Beyond Medical Technologies (DOCT) has announced plans to consolidate its common shares on a ten-to-one basis.
The consolidation will take effect from December 30, 2022.
The name of the company and trading symbol will remain the same after the consolidation. The new CUSIP number will be 088641204, and the new ISIN number will be CA0886412042 for the post-consolidation common shares.
No fractional common shares will be issued upon the consolidation. Fractional common shares will be rounded up or down to the next whole number as necessary.
The company’s post-consolidation common shares are expected to begin trading on the Canadian Securities Exchange (CSE) on or about December 30, 2022.
The total issued and outstanding number of common shares post-consolidation will be approximately 7,913,975.
The record date for the consolidation is January 3, 2023.
Registered shareholders that hold physical share certificates will receive a letter of transmittal requesting that they forward pre-consolidation common share certificates to the company’s transfer agent.
Beyond Medical is an industrial-cum-technology company with a manufacturing facility located in Delta, British Columbia.
Beyond Medical Technologies Inc. was down 33.33 per cent, trading at $0.01 at 13:04 ET.
